Determination of minimum bactericidal concentration, in single or combination drugs, against Mycobacterium tuberculosis

Future Microbiol. 2020 Jan:15:107-114. doi: 10.2217/fmb-2019-0050. Epub 2020 Feb 17.

Abstract

Aim: To evaluate an assay to detect minimum bactericidal concentration (MBC) in Mycobacterium tuberculosis, using as single model rifampicin, isoniazid, levofloxacin (LVX) and linezolid (LNZ) and in combination. Material & methods: MBCs were carried out directly from resazurin microtiter assay plate and 3D checkerboard in M. tuberculosis H37Rv and five resistant clinical isolates. Results: The proposed MBC assay showed similar values to those determined by MGIT™, used as control. LVX and LNZ's MBC values were close to their MIC values. LNZ or LVX combined with isoniazid and rifampicin showed MBC value reduced in 63.7% of the assays. Conclusion: The proposed assay to determine MBCs of drugs can be applied to the study of new compounds with anti-M. tuberculosis activity to detect their bactericidal effect and also in laboratory routine for clinical dose adjustment of drugs according to the patient's profile.

Keywords: biological assay; broth macrodilution; broth microdilution; isoniazid; levofloxacin; linezolid; microbial susceptibility tests; rifampicin; tuberculosis.

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Drug Resistance, Multiple, Bacterial
  • Drug Synergism
  • Humans
  • Isoniazid / pharmacology
  • Levofloxacin / pharmacology
  • Linezolid / pharmacology
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects*
  • Rifampin / pharmacology
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Levofloxacin
  • Linezolid
  • Isoniazid
  • Rifampin